Effect of Antiseizure Medication on Hormone Levels and Sexual Function in Men With Epilepsy
Sponsor
Beth Israel Deaconess Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00179426
Collaborator
GlaxoSmithKline (Industry)
175
1
80
2.2
Study Details
Study Description
Brief Summary
The purpose of this study is to determine if antiseizure drugs affect hormone levels and sexual function in men with seizures.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This study involves donating two small tubes of blood for hormonal testing, which will be drawn at the same time as your routine blood draw for the monitoring of your antiseizure medication. You will also be asked to fill out a short confidential questionnaire regarding your sexual interest and function.
Study Design
Study Type:
Observational
Time Perspective:
Other
Official Title:
Antiseizure Medication-Induced Elevation of Serum Estradiol and Reproductive Dysfunction in Men With Epilepsy
Study Start Date
:
Oct 1, 1999
Study Completion Date
:
Jun 1, 2006
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 50 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Must be a male between 18-50 years of age
-
Must have seizures
-
Must be on antiseizure medication for at least six months duration
Exclusion Criteria:
- Must not have taken hormones, major tranquilizers or antidepressants for at least 3 months
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Beth Israel Deaconess Medical Center | Boston | Massachusetts | United States | 02215 |
Sponsors and Collaborators
- Beth Israel Deaconess Medical Center
- GlaxoSmithKline
Investigators
- Principal Investigator: Andrew G. Herzog, M.D., M.Sc., Beth Israel Deaconess Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Andrew Herzog,
Professor of Neurology,
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00179426
Other Study ID Numbers:
- 2001P000596
First Posted:
Sep 16, 2005
Last Update Posted:
Mar 13, 2017
Last Verified:
Mar 1, 2017
Keywords provided by Andrew Herzog,
Professor of Neurology,
Beth Israel Deaconess Medical Center
Additional relevant MeSH terms: